Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $923.62 | 57 | 97.9% |
| Education | $20.00 | 1 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $222.31 | 13 | $0 (2024) |
| Allergan Inc. | $144.24 | 10 | $0 (2017) |
| CSL Behring | $100.12 | 5 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $86.17 | 5 | $0 (2023) |
| PFIZER INC. | $83.06 | 6 | $0 (2022) |
| Chiesi USA, Inc. | $75.67 | 5 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $48.69 | 4 | $0 (2021) |
| UCB, Inc. | $48.37 | 3 | $0 (2023) |
| Octapharma USA, Inc. | $47.22 | 2 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $40.94 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $67.96 | 3 | Octapharma USA, Inc. ($47.22) |
| 2023 | $178.30 | 10 | AstraZeneca Pharmaceuticals LP ($76.13) |
| 2022 | $214.88 | 13 | AstraZeneca Pharmaceuticals LP ($96.28) |
| 2021 | $74.93 | 4 | Alexion Pharmaceuticals, Inc. ($24.11) |
| 2020 | $40.73 | 3 | AstraZeneca Pharmaceuticals LP ($29.16) |
| 2019 | $29.54 | 2 | CSL Behring ($17.23) |
| 2018 | $128.85 | 9 | Chiesi USA, Inc. ($47.12) |
| 2017 | $208.43 | 14 | Allergan Inc. ($144.24) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | Octapharma USA, Inc. | BALFAXAR (Biological) | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: INTENSIVE CAREEMERGENCY | ||||||
| 09/30/2024 | Octapharma USA, Inc. | BALFAXAR (Biological) | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: INTENSIVE CAREEMERGENCY | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Rare Disease | ||||||
| 12/04/2023 | CSL Behring | Kcentra (Biological) | Education | In-kind items and services | $20.00 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 12/04/2023 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/14/2023 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/11/2023 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Neurology | ||||||
| 08/25/2023 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: Neurology | ||||||
| 05/25/2023 | Chiesi USA, Inc. | CLEVIPREX (Drug), KENGREAL | Food and Beverage | Cash or cash equivalent | $14.59 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/12/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/09/2023 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Neurology | ||||||
| 03/20/2023 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/08/2023 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/13/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/12/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/12/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/14/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/18/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/08/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/09/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/09/2022 | Chiesi USA, Inc. | CLEVIPREX (Drug) | Food and Beverage | Cash or cash equivalent | $13.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/04/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/02/2022 | Alexion Pharmaceuticals, Inc. | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Rare Disease | ||||||
| 01/27/2022 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $17.81 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 1,492 | 1,522 | $1.1M | $141,374 |
| 2022 | 5 | 1,189 | 1,209 | $797,611 | $118,155 |
| 2021 | 6 | 1,002 | 1,022 | $654,784 | $110,220 |
| 2020 | 9 | 1,078 | 1,087 | $647,888 | $100,290 |
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 639 | 653 | $705,304 | $94,543 | 13.4% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 214 | 218 | $159,592 | $21,891 | 13.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 104 | 105 | $146,071 | $18,281 | 12.5% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 62 | 62 | $23,932 | $3,485 | 14.6% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 473 | 484 | $18,876 | $3,174 | 16.8% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 516 | 526 | $568,208 | $84,727 | 14.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 76 | 76 | $105,716 | $14,981 | 14.2% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 111 | 112 | $81,984 | $11,617 | 14.2% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 64 | 64 | $24,894 | $3,939 | 15.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 422 | 431 | $16,809 | $2,891 | 17.2% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 394 | 404 | $436,496 | $76,143 | 17.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 74 | 74 | $102,934 | $17,212 | 16.7% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 97 | 98 | $71,736 | $10,051 | 14.0% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 68 | 68 | $26,248 | $3,948 | 15.0% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 357 | 366 | $14,274 | $2,458 | 17.2% |
| 99282 | Emergency department visit, low to moderately severe problem | Facility | 2021 | 12 | 12 | $3,096 | $407.22 | 13.2% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 364 | 368 | $397,456 | $60,391 | 15.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 96 | 96 | $133,552 | $20,675 | 15.5% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 63 | 63 | $46,116 | $6,560 | 14.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 77 | 77 | $21,415 | $4,686 | 21.9% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 65 | 65 | $25,090 | $3,484 | 13.9% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 347 | 351 | $13,689 | $2,431 | 17.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 44 | 45 | $8,370 | $1,975 | 23.6% |
| 94640 | Respiratory inhaled pressure or nonpressure treatment to relieve airway obstruction or for sputum specimen | Office | 2020 | 11 | 11 | $1,100 | $87.78 | 8.0% |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | Office | 2020 | 11 | 11 | $1,100 | $0.60 | 0.1% |
About Dr. Aryeh Pessah, MD
Dr. Aryeh Pessah, MD is a Emergency Medical Services healthcare provider based in Boca Raton, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1841287356.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Aryeh Pessah, MD has received a total of $943.62 in payments from pharmaceutical and medical device companies, with $67.96 received in 2024. These payments were reported across 58 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($923.62).
As a Medicare-enrolled provider, Pessah has provided services to 4,761 Medicare beneficiaries, totaling 4,840 services with total Medicare billing of $470,039. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Practice Information
- Specialty Emergency Medical Services
- Location Boca Raton, FL
- Active Since 09/29/2005
- Last Updated 07/08/2007
- Taxonomy Code 207PE0004X
- Entity Type Individual
- NPI Number 1841287356
Products in Payments
- BRILINTA (Drug) $172.41
- ELIQUIS (Drug) $103.42
- AVYCAZ (Drug) $89.37
- Kcentra (Biological) $86.52
- XARELTO (Drug) $86.17
- CLEVIPREX (Drug) $75.67
- DALVANCE (Drug) $54.87
- Nayzilam (Drug) $48.37
- BALFAXAR (Biological) $47.22
- ANDEXXA (Biological) $37.57
- LOKELMA (Drug) $29.16
- CHANTIX (Drug) $28.33
- Andexxa (Drug) $24.11
- PRECEDEX (Drug) $17.22
- Multiple Products (Biological) $13.60
- EKOSONIC (Device) $11.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medical Services Doctors in Boca Raton
Jamie Alvarez, Md, MD
Emergency Medical Services — Payments: $1,252
Adam Bernstein, Md, MD
Emergency Medical Services — Payments: $1,242
David Leeman, Md, MD
Emergency Medical Services — Payments: $1,195
Gail Kwal, Md, MD
Emergency Medical Services — Payments: $1,097
Evan Goldstein, Md, MD
Emergency Medical Services — Payments: $959.72
Terry Cohen, Md, MD
Emergency Medical Services — Payments: $739.85